The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.89
Bid: 0.86
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.06 (6.977%)
Open: 0.89
High: 0.89
Low: 0.89
Prev. Close: 0.89
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re: Valuation Reporting Frequency

12 Feb 2010 09:31

RNS Number : 0700H
J.P. Morgan Private Equity Ltd
12 February 2010
 



J.P. Morgan Private Equity Increases Frequency of Private Equity Valuation Reporting

 * * *

GUERNSEY, 12 FEBRUARY 2010

J.P. Morgan Private Equity Limited ("JPEL" or the "Company"), the London Stock Exchange listed private equity secondary fund, is pleased to announce that the Company will be increasing the frequency of the reporting and valuation of its private equity portfolio.

Since the Company's IPO at June 2005, JPEL has updated the values of its private equity portfolio on a quarterly basis. Beginning with the month that ended 31 January 2010, the Company began valuing its private equity portfolio on a monthly basis.

Since inception, JPEL has always placed emphasis on investor communications and reporting. Increasing the frequency of valuations for the private equity portfolio is a logical and welcomed continuation of this effort. The Manager believes that reporting private equity valuations twelve times per year will enable the Manager to efficiently communicate its activity in the secondary market as well as the overall performance of the portfolio.

JPEL's primary strategy is to acquire secondary market portfolios of direct fund investments, significantly invested partnership interests and partially drawn commitments, in order to accelerate NAV development. JPEL employs an opportunistic, deep value private equity investment strategy and focuses on value-oriented investments with potential for early return of capital. From inception through 31 December 2009, JPEL's NAV per US$ Equity Share has grown 25.5% versus declines of 6.4% and 47.5% in the S&P 500 and LPX indices, respectively.

Please refer to page 2 of this press release for additional information on JPEL's Valuation and Reporting Policy.

* * *

About J.P. Morgan Private Equity Limited

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPEZ, JPZZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market. The Company's capital structure consists of three classes of shares: Equity Shares and two classes of Zero Dividend Preference Shares due 2013 and 2015, respectively. JPEL issued warrants free of subscription cost to shareholders on record as of 17 August 2009. The warrants are publicly traded on the London Stock Exchange under the symbol "JPWW."

J.P. Morgan Private Equity LimitedTroy Duncan / Gregory Getschow Telephone: +44 (0) 20 7742 3032 / +1 212 648 1150

Rosemary DeRise Telephone: + 1 212 648 2980

Peregrine CommunicationsAnthony Payne Telephone: +44 (0) 20 3178 6869

* * *

 

VALUATION POLICY AND METHODOLOGY

Valuation reporting policy

 

The Net Asset Value of the Company is calculated by HSBC Management (Guernsey) Limited and published monthly with the relevant Valuation Point being 5.00 p.m. (Guernsey time) on the last Business Day of each month. Each monthly Net Asset Value is published through a Regulatory News Service (RNS) announcement normally within 20 Business Days of such month end. Valuations produced by the Manager as at the relevant month end are conclusive and binding on all Shareholders. In addition to the planned new reporting cycle described above, the Company and the Manager may, in their sole discretion, arrange for additional valuations to be published or extend the 20 Business Day period to cater for exceptional circumstances or significant new developments.

 

 

Private equity valuation methodology

The Board values the investments in the Private Equity Portfolio on the Manager's advice by following the recommendations of either the International Private Equity and Venture Capital Valuation Guidelines (IPEVCG) or standard industry practice. For unquoted fund investments, the value is the most recent valuation placed on a fund by the respective private equity manager, although the Manager may recommend to the Board that an adjustment to such valuation be made if necessary to reflect cash flows between the Company and the fund(s) concerned which occur between the private equity manager's valuation date and the Company's monthly valuation dates. In the event that the Company directly holds publicly traded portfolio companies, the Manager may recommend that an adjustment to such valuation be made if necessary. The Manager will endeavour to include the most recent valuations received by the respective private equity manager at the time in which the monthly Net Asset Value is published.

 

The valuation policies used by many of the private equity managers in undertaking such valuations is generally in line with the recommendations of either the International Private Equity and Venture Capital Valuation Guidelines (IPEVCG) or standard industry practice.

 

All valuations of fund interests include a provision for carried interest, where appropriate, payable to the relevant private equity sponsor.

 

While the Board's normal policy is to adopt the private equity manager's valuations and to reflect in the valuation of the Company Portfolio any adjustment to the valuation of their respective funds made by private equity sponsors, on occasions it may depart from this policy in the following circumstances:

 

·; the Manager may recommend the Board not to adopt an upwards adjustment if in its opinion the adjustment made or proposed by the relevant private equity manager is not prudent;

·; the Manager may recommend that the Board make a downward adjustment to the valuation of a fund interest in the Company Portfolio which has not been made or proposed by the private equity manager if they receive relevant information which has not been notified to them by the private equity manager or if they form a different and more cautious view than that held by the private equity manager; and

·; the Manager may recommend that the Board make an upward adjustment to the valuation of a fund interest in the Company Portfolio which has not been made or proposed by the private equity manager if they receive relevant information that has occurred subsequent to the issuance of the general partner valuation, such as in cases of announcements of the pending public offering or sale of a portfolio company.

 

Secondary Portfolios

The Company may acquire secondary interests at either a premium or a discount to the respective private equity sponsor's valuation by following the International Private Equity and Venture Capital Valuation Guidelines. The Company will maintain values for any secondary interests at the price at which they were purchased until the receipt of the first valuation report from the respective private equity sponsor after the date of acquisition, at which point the acquired interests will be valued according to the Company's standard ongoing valuation methodology.

 

The calculation of the Net Asset Value will only be suspended in circumstances where the underlying data necessary to value the investments of the Company cannot readily, or without undue expenditure, be obtained. Details of any suspension in making such calculations will be announced through an RNS.

 

* * *

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRTTMLTMBJBMMM
Date   Source Headline
15th Nov 201710:11 amRNSRetirement of 2017 ZDP Shares
9th Nov 20177:00 amRNS2017 AGM CIRCULAR
27th Oct 20174:33 pmRNSHolding(s) in Company
27th Oct 20177:00 amRNSNet Asset Value(s) - September 2017
17th Oct 20179:40 amRNSDirector Declaration
13th Oct 20177:00 amRNSTiming of Retirement of 2017 ZDP Shares
11th Oct 20177:00 amRNSBerkshire Partners Acquires Accela
28th Sep 20177:00 amRNSAnnual Financial Report
27th Sep 20179:45 amRNSDirector Update
26th Sep 201711:11 amRNSNet Asset Value(s) - August 2017
7th Sep 20177:00 amRNSNet Asset Value(s) - July 2017
21st Aug 20172:21 pmRNSHolding(s) in Company
3rd Aug 20177:00 amRNSNet Asset Value(s) - June 2017
5th Jul 20175:50 pmRNSNet Asset Value(s) - May 2017 Correction
30th Jun 20179:52 amRNSNet Asset Value(s) - May 2017
2nd Jun 20177:00 amRNSNet Asset Value(s) - April 2017
30th May 20174:34 pmRNSHolding(s) in Company
25th May 20174:42 pmRNSHolding(s) in Company
2nd May 20173:50 pmRNSNotice to Shareholders - Total Voting Rights
2nd May 20177:00 amRNSCompletion of Mandatory Redemption_ April 2017
24th Apr 20176:15 pmRNSNotification of Dealings in Shares
21st Apr 20177:00 amRNSQuarter End Review for March 2017
12th Apr 20177:00 amRNSMandatory Redemption_US$ Equity Shares_April 2017
11th Apr 20175:22 pmRNSNet Asset Value(s) - March 2017
7th Apr 20177:00 amRNSNet Asset Value(s) - February 2017
28th Mar 20174:56 pmRNSHalf-year Report
16th Mar 20176:04 pmRNSSale of Datamars
3rd Mar 20173:15 pmRNSNet Asset Value(s) - January 2017
17th Feb 20172:40 pmRNSFortress Softbank Merger
14th Feb 20173:35 pmRNSHolding(s) in Company
13th Feb 20172:04 pmRNSNet Asset Value(s) - December 2016
10th Jan 20177:00 amRNSNet Asset Value(s) - November 2016
23rd Dec 20161:16 pmRNSSALE OF INNOVIA
15th Dec 20167:00 amRNSCompletion of Mandatory Redemption_Dec 2016
6th Dec 20162:29 pmRNSChange of Registered Office
30th Nov 20169:29 amRNSMandatory Redemption - US$ Equity Shares -Dec 2016
29th Nov 20167:00 amRNSNet Asset Value - October 2016
8th Nov 20162:58 pmRNSJPEL Announces New Chairman
31st Oct 201610:32 amRNSNet Asset Value - September 2016
28th Oct 20164:42 pmRNSResults of AGM and Separate Class Meeting
20th Oct 20163:49 pmRNSNet Asset Value - August 2016
14th Oct 201610:27 amRNSAGM CIRCULAR - Correction to Typographical Error
11th Oct 20164:20 pmRNS2016 AGM CIRCULAR
3rd Oct 20167:00 amRNSAnnual Report and Financial Statements
2nd Sep 20165:00 pmRNSNet Asset Value(s)
24th Aug 20162:06 pmRNSNet Asset Value(s)
1st Aug 20165:22 pmRNSHolding(s) in Company
5th Jul 20164:01 pmRNSResults of EGM and Separate Class Meeting
16th Jun 20163:41 pmRNSHolding(s) in Company
15th Jun 20164:00 pmRNSShareholder Meeting Circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.